Description
Calcitriol has been considered as trusted option for the treatment of Osteoporosis, because it increases intestinal calcium absorption, stimulates bone synthesis and decrease bone resorption.
Calcitriol is the physiologically most active form of vitaminD3 which facilitates calcium absorption.
Double blind clinical trials revealed that Calcitriol significantly increased bone mineral density by decreasing bone resorption.
Treatment with Calcitriol for 2 years in postmenopausal osteoporotic women increase spine density and total body calcium.
Calcitriol significantly reduces the rate of new vertebral fractures in postmenopausal osteoporotic women.
